Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Bone Marrow Transplantation|March 26, 2021
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groupsMarie Robin, Raphael Porcher, Corentin Orvain, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationKarina Tozatto-Maio, Federica Giannotti, Myriam Labopin, et al.
Journal of Hematology & Oncology|April 26, 2026
Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2Javier Muñoz, Frederick L Locke, Patrick M Reagan, et al.
Bone Marrow Transplantation|May 29, 2025
Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortiumChrystel Marton, Béatrice Clémenceau, Guillaume Dachy, et al.
Blood|August 5, 2024
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDSEsteban Arrieta-Bolaños, Lars L J van der Burg, Tobias Gedde-Dahl, et al.
Bone Marrow Transplantation|June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMTRaynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Transplantation and Cellular Therapy|September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFiroozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.
Pageof 18